Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Knowing the right time to start planning for retirement is essential. Discover the best age to begin securing your financial future.
26,342 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
When mortgage markets swung on interest-rate headlines, one fund pressed deeper into PennyMac. This article explains ...
A sharp move in Thomson Reuters stock has investors buzzing. AI-powered products and enterprise deals are at the hear...
On Tuesday, Broadcom shifted higher as investors rotated into hardware names and welcomed a positive analyst update. ...
Costco just signed massive Florida land deal signals a bold expansion move. This article breaks down what it means fo...
When a company's CFO makes a notable stock purchase, investors pay attention. This article breaks down what nomad foo...
Ambiq Micro shares jumped as investors priced in stronger demand for ultra-low-power edge AI technology. This article...
A fresh rally in semiconductor names has investors buzzing about CPU pricing power and AI infrastructure demand. This...
Turning Point Brands stock captured attention with a double-digit sales lift and solid earnings signs that stunned ma...
A SpaceX AI push could rewrite how we think about tech bets. If spacex just spent billion, investors should watch how...
Investing in cutting-edge robotics can yield outsized gains or steep losses. This article dissects the idea of serve ...
Investors are watching Crinetics' Q1 2026 results for clues on milestones, cash runway, and partnerships. This guide ...